INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 80 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $15,000 | -11.8% | 23,907 | +61.0% | 0.00% | – |
| Q1 2022 | $17,000 | -80.7% | 14,849 | -62.0% | 0.00% | – |
| Q4 2021 | $88,000 | -53.4% | 39,090 | -29.3% | 0.00% | -100.0% |
| Q3 2021 | $189,000 | +8.6% | 55,269 | -50.6% | 0.00% | -50.0% |
| Q3 2016 | $174,000 | +241.2% | 111,811 | +191.5% | 0.00% | – |
| Q2 2016 | $51,000 | -56.0% | 38,353 | +73.6% | 0.00% | -100.0% |
| Q1 2016 | $116,000 | -46.8% | 22,097 | +71.0% | 0.00% | 0.0% |
| Q4 2014 | $218,000 | +6.9% | 12,923 | -15.1% | 0.00% | 0.0% |
| Q3 2014 | $204,000 | -57.4% | 15,213 | -59.5% | 0.00% | -66.7% |
| Q2 2014 | $479,000 | -14.5% | 37,599 | -20.2% | 0.00% | +50.0% |
| Q1 2014 | $560,000 | +7.3% | 47,125 | +24.6% | 0.00% | 0.0% |
| Q4 2013 | $522,000 | -60.7% | 37,825 | -50.3% | 0.00% | -60.0% |
| Q3 2013 | $1,328,000 | -24.4% | 76,170 | -29.8% | 0.01% | -44.4% |
| Q2 2013 | $1,757,000 | – | 108,483 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |